Company

Managing Team

Honorary Founder

陳垣崇, M.D., Ph.D / 榮譽創辦人

Yuan-Tsong (Y-T) Chen

M. D. National Taiwan University, College of Medicine, Taiwan

Ph.D. Columbia University, New York, USA

 

Professor, Duke University Medical Center

Distinguished Research Fellow and Academician, Academia Sinica

Director, Institute of Biomedical Sciences, Academia Sinica, (2001-2010)

 

Dr. Y.T. Chen is the physician/scientist who discovered the only life-saving treatment for Pompe Disease and has led the scientific field in another life-saving discoveries: the screening markers for prevention of Stevens-Johnson syndrome induced by drugs such as carbamazepine and allopurinol, and for prediction of warfarin dosage. Dr. Chen is the Director Emeritus and Distinguished Research Fellow of Institute of Biomedical Sciences, Academia Sinica. Dr. Chen also has a professorship appointment at Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, and has been the Chief of Division of Medical Genetics from 1993 to 2004. He was also the President of Taiwan Human Genetics Society, and Board of Director of Taiwan Foundation for Rare Disorders (2005-2011). Dr. Chen’s distinguished career also includes many honors and awards, and has presented over 250 scientific publications. He is an elected member of Academia Sinica and of the Academy Sciences for the Developing World.

*Dr. Chen is not involved in Pharmigene's operation. He serves as the Chair of Scientific Advisory Board for Pharmigene.


Chairman & CEO

Daniel Huang  

M.S. Institute of Biochemical Science, National Taiwan University

 

Experience

CEO, Genomics BioSci & Tech. Ltd.

President, Xinscience Biotech

General Manager, Taiwan, Life Technologies

Director for Applied Biosystems, Greater China, Life Technologies